Pritesh Shah is now serving in a new position at NovoCure Ltd.
Jul 07, 2018
Board and Executive Moves
Chief Commercial Officer at NovoCure Ltd.
In The News
Novocure Receives CE Mark for NovoTTF-100L(TM) System; The application of CE mark enables Novocure to commercialize the NovoTTF-100L System as a treatment for Malignant Pleural Mesothelioma in the European Union and Switzerland
Nov 11, 2020 - Business Wire
Oct 30, 2020 - Nasdaq
Oct 08, 2020 - RelSci